Compile Data Set for Download or QSAR
maximum 50k data
Found 582 with Last Name = 'kim' and Initial = 'ny'
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM511035(US11078206, Example 1)
Affinity DataIC50:  0.100nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM511036(US11078206, Example 2)
Affinity DataIC50:  0.100nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489529(US10961247, Ex. No. 136)
Affinity DataIC50:  0.100nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489424(US10961247, Ex. No. 39)
Affinity DataIC50:  0.100nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489423(US10961247, Ex. No. 38)
Affinity DataIC50:  0.100nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489421(US10961247, Ex. No. 37)
Affinity DataIC50:  0.100nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM511037(US11078206, Example 3)
Affinity DataIC50:  0.100nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489477(US10961247, Ex. No. 89)
Affinity DataIC50:  0.138nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555143(US11339167, Example 6)
Affinity DataIC50:  0.200nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555145(US11339167, Example 7)
Affinity DataIC50:  0.200nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555146(US11339167, Example 8)
Affinity DataIC50:  0.200nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555150(US11339167, Example 12)
Affinity DataIC50:  0.200nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555152(US11339167, Example 14)
Affinity DataIC50:  0.200nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555160(US11339167, Example 21)
Affinity DataIC50:  0.200nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555141(US11339167, Example 25 | US11339167, Example 4 | U...)
Affinity DataIC50:  0.200nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555165(US11339167, Example 26)
Affinity DataIC50:  0.200nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489463(US10961247, Ex. No. 75)
Affinity DataIC50:  0.200nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489476(US10961247, Ex. No. 88)
Affinity DataIC50:  0.200nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489542(US10961247, Ex. No. 149)
Affinity DataIC50:  0.200nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555141(US11339167, Example 25 | US11339167, Example 4 | U...)
Affinity DataIC50:  0.200nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489425(US10961247, Ex. No. 40)
Affinity DataIC50:  0.200nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489439(US10961247, Ex. No. 52)
Affinity DataIC50:  0.200nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489447(US10961247, Ex. No. 60)
Affinity DataIC50:  0.200nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489449(US10961247, Ex. No. 62)
Affinity DataIC50:  0.200nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM511046(US11078206, Example 12)
Affinity DataIC50:  0.200nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM511041(US11078206, Example 7)
Affinity DataIC50:  0.200nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM511040(US11078206, Example 6)
Affinity DataIC50:  0.200nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM511038(US11078206, Example 4)
Affinity DataIC50:  0.200nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489458(US10961247, Ex. No. 70)
Affinity DataIC50:  0.200nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Gwangju Institute Of Science And Technology

Curated by ChEMBL
LigandPNGBDBM144315(Gilteritinib | US11512074, Example T-9 | US8969336...)
Affinity DataIC50:  0.290nMAssay Description:Inhibition of FLT3 expressed in human SEMK2 cells assessed as reduction in FLT3 phosphorylation incubated for 1 hr by immunoblotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM563333(US11407754, Example 7)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM563334(US11407754, Example 8)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM563335(US11407754, Example 9)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM511042(US11078206, Example 8)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM511043(US11078206, Example 9)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555138(US11339167, Example 1)
Affinity DataIC50:  0.300nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555139(US11339167, Example 2)
Affinity DataIC50:  0.300nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555140(US11339167, Example 3)
Affinity DataIC50:  0.300nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555147(US11339167, Example 9)
Affinity DataIC50:  0.300nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555149(US11339167, Example 11)
Affinity DataIC50:  0.300nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555151(US11339167, Example 13)
Affinity DataIC50:  0.300nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM555169(US11339167, Example 30)
Affinity DataIC50:  0.300nMAssay Description:Specifically, the inhibitory activities against JAK3 and BTK kinase were measured using a JAK3 kinase assay kit (Promega, V9441) and a BTK kinase ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM563303(US11407754, Example 1)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinases inhibitory activities were measured for the compounds prepared in the Examples through in vitro analysis on the ADP Glow (Glo) p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489400(US10961247, Ex. No. 15)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489403(US10961247, Ex. No. 18)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489430(US10961247, Ex. No. 44 | US10961247, Ex. No. 90)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489443(US10961247, Ex. No. 56)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489451(US10961247, Ex. No. 63)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489457(US10961247, Ex. No. 69)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM489464(US10961247, Ex. No. 76)
Affinity DataIC50:  0.300nMAssay Description:JAK3 and BTK kinase inhibitory activities were measured for the compounds prepared in the above Examples through in vitro analysis on the ADP Glow (G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 582 total ) | Next | Last >>
Jump to: